These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29146652)

  • 41. Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines.
    Zhou YF; Liu N; Wang P; Jeong Yang J; Song XY; Pan XF; Zhang X; He M; Li H; Gao YT; Xiang YB; Wu T; Yu D; Pan A
    Hypertension; 2020 Sep; 76(3):750-758. PubMed ID: 32713271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modelling the cost effectiveness of antidepressant treatment in primary care.
    Revicki DA; Brown RE; Palmer W; Bakish D; Rosser WW; Anton SF; Feeny D
    Pharmacoeconomics; 1995 Dec; 8(6):524-40. PubMed ID: 10160081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium.
    Borisenko O; Lukyanov V; Debergh I; Dillemans B
    J Med Econ; 2018 Apr; 21(4):365-373. PubMed ID: 29271279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
    Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
    J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
    Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA
    JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study.
    Vasudeva E; Moise N; Huang C; Mason A; Penko J; Goldman L; Coxson PG; Bibbins-Domingo K; Moran AE
    Am J Hypertens; 2016 Oct; 29(10):1195-205. PubMed ID: 27172970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction.
    Teti VP; Akdagli S; Most SP
    JAMA Facial Plast Surg; 2016 May; 18(3):165-70. PubMed ID: 26747790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands.
    Boersma C; Carides GW; Atthobari J; Voors AA; Postma MJ
    Clin Ther; 2007 May; 29(5):963-971. PubMed ID: 17697915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
    Majumdar SR; Lier DA; Leslie WD
    J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Cost-Effectiveness of Dual Mobility Implants for Primary Total Hip Arthroplasty: A Computer-Based Cost-Utility Model.
    Barlow BT; McLawhorn AS; Westrich GH
    J Bone Joint Surg Am; 2017 May; 99(9):768-777. PubMed ID: 28463921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic Decision Model Suggests Total Shoulder Arthroplasty is Superior to Hemiarthroplasty in Young Patients with End-stage Shoulder Arthritis.
    Bhat SB; Lazarus M; Getz C; Williams GR; Namdari S
    Clin Orthop Relat Res; 2016 Nov; 474(11):2482-2492. PubMed ID: 27457626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Bryant KB; Moran AE; Kazi DS; Zhang Y; Penko J; Ruiz-Negrón N; Coxson P; Blyler CA; Lynch K; Cohen LP; Tajeu GS; Fontil V; Moy NB; Ebinger JE; Rader F; Bibbins-Domingo K; Bellows BK
    Circulation; 2021 Jun; 143(24):2384-2394. PubMed ID: 33855861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood pressure control in treated hypertensive Middle Eastern patients: a post hoc analysis based on JNC8 definitions.
    Alhaddad IA; Hamoui O; Hammoudeh A; Mallat S
    Vasc Health Risk Manag; 2019; 15():35-46. PubMed ID: 30881006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
    Wu B; Chen H; Shen J; Ye M
    Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost effectiveness of memantine in Alzheimer's disease: an analysis based on a probabilistic Markov model from a UK perspective.
    Jones RW; McCrone P; Guilhaume C
    Drugs Aging; 2004; 21(9):607-20. PubMed ID: 15260515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A health economic lifetime treatment pathway model for low back pain in Sweden.
    Olafsson G; Jonsson E; Fritzell P; Hägg O; Borgström F
    J Med Econ; 2017 Dec; 20(12):1281-1289. PubMed ID: 28840772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.